Motor cortical excitability and clinical response to rTMS in depression

Journal of Affective Disorders

Volumn 82, Issue 1, 2004, Pages 71-76

  Fitzgerald, Paul B ^a   Brown, Timothy L ^a   Marston, Natasha A U ^a   Daskalakis, Z Jeff ^b   De Castella, Anthony ^a   Bradshaw, John L ^c   Kulkarni, Jayashri ^a  

^a MONASH UNIVERSITY   (Australia)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Cortical excitability; Cortical inhibition; Depression; Prefrontal cortex; Repetitive transcranial magnetic stimulation

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; QUETIAPINE; REBOXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ARTICLE; BIPOLAR I DISORDER; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOTOR CORTEX; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGHT HEMISPHERE; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; DEPRESSIVE DISORDER; ELECTRIC STIMULATION THERAPY; ELECTROMAGNETIC FIELDS; ELECTROMYOGRAPHY; FUNCTIONAL LATERALITY; HUMANS; MOTOR CORTEX; TREATMENT OUTCOME;

EID: 4744341785     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2003.09.014     Document Type: Article

References (21)

1. Abou-Saleh M.T., Al Suhaili A.R., Karim L., Prais V., Hamdi E. Single photon emission tomography with 99 m Tc-HMPAO in Arab patients with depression. J. Affect. Disord. 55:1999;115-123
2. Baxter L.R. Jr., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., Gerner R.H., Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry. 46:1989;243-250
3. Beck A., Ward C., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571
4. Daskalakis Z.J., Christensen B.K., Chen R., Fitzgerald P.B., Zipursky R., Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch. Gen. Psychiatry. 59:2002;347-354
5. Davidson J.R., Meltzer-Brody S.E. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J. Clin. Psychiatry. 60:(Suppl. 7):1999;4-9. (discussion 10-1).
6. Dolberg O.T., Dannon P.N., Schreiber S., Grunhaus L. Magnetic motor threshold and response to TMS in major depressive disorder. Acta Psychiatr. Scand. 106:2002;220-223
7. Fitzgerald P.B., Brown T., Daskalakis Z.J., Kulkarni J. A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res. Neuroimaging. 114:2002;11-22
8. Fitzgerald P.B., Brown T., Marston N.A.U., Daskalakis Z.J., de Castella A., Kulkarni J. A double-blind placebo controlled trial of transcranial magnetic stimulation in the treatment of depression. Arch. Gen. Psychiatry. 60:2003;1002-1008
9. Kimbrell T.A., Little J.T., Dunn R.T., Frye M.A., Greenberg B.D., Wassermann E.M., Repella J.D., Danielson A.L., Willis M.W., Benson B.E., Speer A.M., Osuch E., George M.S., Post R.M. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol. Psychiatry. 46:1999;1603-1613
10. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. (London). 471:1993;501-519
11. Maeda F., Keenan J.P., Pascual-Leone A. Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation. Br. J. Psychiatry. 177:2000;169-173
12. Manganotti P., Bortolomasi M., Zanette G., Pawelzik T., Giacopuzzi M., Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J. Neurol. Sci. 184:2001;27-32
13. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389
14. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9:1971;97-113
15. Overall J.E., Gorham D. The Brief Psychiatric Rating Scale. Psychol. Rep. 10:1962;799-812
16. Parker G., Hadzi-Pavlovic D., Boyce P., Wilhelm K., Brodaty H., Mitchell P., Hickie I., Eyers K. Classifying depression by mental state signs. Br. J. Psychiatry. 157:1990;55-65
17. Teneback C.C., Nahas Z., Speer A.M., Molloy M., Stallings L.E., Spicer K.M., Risch S.C., George M.S. Changes in prefrontal cortex and paralimbic activity in depression following 2 weeks of daily left prefrontal TMS. J. Neuropsychiatry Clin. Neurosci. 11:1999;426-435
18. Waldvogel D., van Gelderen P., Muellbacher W., Ziemann U., Immisch I., Hallett M. The relative metabolic demand of inhibition and excitation. Nature. 406:2000;995-998
19. Ziemann U., Rothwell J.C., Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J. Physiol. (London). 493:1996;873-881
20. Ziemann U., Lonnecker S., Steinhoff B.J., et al. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial stimulation study. Ann. Neurol. 40:1996;367-378
21. Ziemann U., Tergau F., Bruns D., Baudewig J., Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr. Clin. Neurophysiol. 105:1997;430-437